MUCOSIS LIFE SCIENCE PRIVATE LIMITE
⚠️ High Risk
FEI: 3021241804 • Mumbai, Maharashtra • INDIA
FEI Number
3021241804
Location
Mumbai, Maharashtra
Country
INDIAAddress
03 Satyam Apartment, Shop No, Mumbai, Maharashtra, India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/19/2022 | 60MCY99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/7/2022 | 65PCY02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/7/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/5/2022 | 60MCY99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/15/2022 | 66SCY51TADALAFIL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 61NCA74MODAFINIL (ANTI-DEPRESSANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/12/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/11/2022 | 64SCY29ZOPICLONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/11/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/11/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/25/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/25/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/25/2022 | 65PCA02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/24/2022 | 65PCA02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/24/2022 | 65PCA02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/18/2022 | 64SCY29ZOPICLONE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/17/2022 | 66SCA51TADALAFIL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/15/2022 | 66SCA51TADALAFIL | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/14/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/14/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/13/2022 | 60MCY99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/11/2022 | 65PCS02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/7/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/7/2022 | 65PCA02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/7/2022 | 60MCA99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/7/2022 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/7/2022 | 65PCA02SILDENAFIL CITRATE (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/2/2022 | 60MCY99ANALGESIC, NARCOTIC, N.E.C. | 75UNAPPROVED | Division of Northern Border Imports (DNBI) |
Frequently Asked Questions
What is MUCOSIS LIFE SCIENCE PRIVATE LIMITE's FDA import refusal history?
MUCOSIS LIFE SCIENCE PRIVATE LIMITE (FEI: 3021241804) has 43 FDA import refusal record(s) in our database, spanning from 2/2/2022 to 4/19/2022.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. MUCOSIS LIFE SCIENCE PRIVATE LIMITE's FEI number is 3021241804.
What types of violations has MUCOSIS LIFE SCIENCE PRIVATE LIMITE received?
MUCOSIS LIFE SCIENCE PRIVATE LIMITE has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about MUCOSIS LIFE SCIENCE PRIVATE LIMITE come from?
All FDA import refusal data for MUCOSIS LIFE SCIENCE PRIVATE LIMITE is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.